Tarlatamab in Small-Cell Lung Cancer after Platinum-Based Chemotherapy

Giannis Mountzios

Fourth Department of Medical Oncology and Clinical Trials Unit, Henry Dunant Hospital Center, Athens

Longhua Sun

Department of Pulmonary and Critical Care Medicine, First Affiliated Hospital of Nanchang University, Nanchang, China

Byoung Chul Cho

Umut Demirci

Memorial Ankara Hospital, Ankara, Turkey

Sofia Baka

European Interbalkan Medical Center, Thessaloniki, Greece

Mahmut Gümüş

Istanbul Medeniyet University, Istanbul, Turkey

Antonio Lugini

Medical Oncology Unit, Azienda Ospedaliera San Giovanni Addolorata Hospital, Rome

Bo Zhu

Yan Yu

Department of Respiratory Oncology Harbin Medical University Cancer Hospital Harbin China

Ippokratis Korantzis

Department of Medical Oncology, St. Luke’s Hospital, Thessaloniki, Greece

Ji-Youn Han

Tudor-Eliade Ciuleanu

Institutul Oncologic Prof. Dr. Ion Chiricuţă and University of Medicine and Pharmacy Iuliu Haţieganu, Cluj-Napoca, Romania

Myung-Ju Ahn

Department of Hematology and Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea

Pedro Rocha

Department of Medical Oncology Service, Vall d’Hebron University Hospital and Vall d’Hebron Institute of Oncology, Barcelona

Julien Mazières

Centre Hospitalier Universitaire de Toulouse, Université Paul Sabatier, Toulouse, France

Sally C.M. Lau

Department of Medical Oncology, NYU Langone Health Perlmutter Cancer Center, New York

Martin Schuler

Fiona Blackhall

Tatsuya Yoshida

Department of Chemistry, Faculty of Science, Kyushu University, 744 Motooka, Nishi-ku, Fukuoka 819-0395, Japan

Taofeek K. Owonikoko

University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore

Luis Paz-Ares

Hospital Universitario 12 de Octubre, Universidad Complutense de Madrid, Madrid

Tony Jiang

Amgen, Thousand Oaks, CA

Ali Hamidi

Amgen, Thousand Oaks, CA

Diana Gauto

Amgen, Thousand Oaks, CA

Gonzalo Recondo

Amgen, Thousand Oaks, CA

Charles M. Rudin